Assembly Biosciences Reports Results for Quarter Ended June 30, 2026

What Happened
Assembly Biosciences, Inc. (ASMB) filed a Form 8-K on August 13, 2026 to announce its financial results for the quarter ended June 30, 2026. The company furnished a press release reporting those quarterly results as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: August 13, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: quarter ended June 30, 2026.
• Disclosure: press release announcing the quarterly financial results included as Exhibit 99.1.
• Filing signed by John O. Gunderson, VP, General Counsel and Corporate Secretary.

Why It Matters
This 8-K notifies investors that Assembly has publicly released its quarterly results; investors should read the attached press release for specifics on revenue, earnings/losses, cash position, and any commentary on operations or guidance. The 8-K itself furnishes the press release but does not replace detailed periodic filings (such as a Form 10-Q), which may follow and provide full financial statements and management discussion and analysis.